In the News

1832 News Items found
Ask the Expert
Pictured: Azeez Farooki
How does having diabetes affect my cancer treatment?
Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic.
Announcement
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute
Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
In the Lab
The 1986 explosion at the Chernobyl nuclear power plant released radioactive particles in every direction.
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl
The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Profile
Pictured: Stephen Long & Alexandria Miller
At Work: Structural Biologist Stephen Long
Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Event
Pictured: Craig Thompson
Watch Webcast of “Major Trends” Seminar — Annual Event for High School Students
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Announcement
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Innovative Partnership Will Speed Drug Discovery and Development
Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.
Profile
Pictured: Emily Foley
At Work: Cell Biologist Emily Foley
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
In the Lab
Mouse glioblastoma tumor with phagocytic macrophages
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Honors
Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Former Memorial Sloan Kettering Researcher James Rothman Among Nobel Prize Winners
James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.
Snapshot
Breast cancer mosaic
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery
Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.